National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2018 (No. 8) (PB 76 of 2018) (Cth)

PB 76 of 2018

National Health (Pharmaceutical Benefits – early supply) Amendment Instrument 2018 (No. 8)

National Health Act 1953

___________________________________________________________________________

I, SEAN LANE, Assistant Secretary (Acting), Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated 28 August 2018

SEAN LANE

Assistant Secretary (Acting)

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

___________________________________________________________________________

1. Name of Instrument

(1)This Instrument is the National Health (Pharmaceutical Benefits – early supply) Amendment Instrument 2018 (No. 8).

(2)This Instrument may also be cited as PB 76 of 2018.

1. Commencement

This Instrument commences on 1 September 2018.

1. Amendment of National Health (Pharmaceutical Benefits—early supply) Instrument 2015 (PB 120 of 2015)

Schedule 1 amends the National Health (Pharmaceutical Benefits—early supply) Instrument 2015 (PB 120 of 2015).

Schedule 1       Amendments

1. Schedule 1, after entry for Balsalazide in the form Capsule containing balsalazide sodium 750 mg

insert:

Baricitinib	Tablet 2 mg	20	28	5
Baricitinib	Tablet 4 mg	20	28	5

1. Schedule 1, after entry for Griseofulvin in the form Tablet 125 mg

insert:

Guanfacine	Tablet 1 mg (as hydrochloride)	20	28	5
Guanfacine	Tablet 2 mg (as hydrochloride)	20	28	5
Guanfacine	Tablet 3 mg (as hydrochloride)	20	28	5
Guanfacine	Tablet 4 mg (as hydrochloride)	20	28	5